Clinical Trial Update: Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update related to cognitive decline and Alzheimer's disease from the Dallas Lifespan Brain Study; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Decline

Snippet

Sponsor: Neil M Rofsky, MD, MHA | Conditions: Alzheimer Disease, Cognitive Decline | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28